Melexis stock: Degroof Petercam raises rating from Reduce to Hold
Published on 10/20/2026 at 15:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRating and reporting date
- Degroof Petercam raised its Melexis rating from Reduce to Hold on October 16, 2026.
- Second-quarter revenue reached EUR 217.06 million, while earnings per share came to EUR 0.76 versus EUR 0.71 forecast.
- Melexis stock costs EUR 56.43 at Lang & Schwarz on October 20, 2026 at 3:34 p.m. CEST, minus 2.96 percent versus the Xetra close of October 19, 2026.
- Melexis is scheduled to publish third-quarter results on October 28, 2026.
Melexis (ISIN BE0165385973) is facing a more cautious analyst stance despite a rating improvement: Beursduivel reported on October 16, 2026 that Degroof Petercam raised its recommendation from Reduce to Hold while keeping its EUR 56.00 price target. Melexis stock was trading at EUR 56.43 at Lang & Schwarz on October 20, 2026 at 3:34 p.m. CEST, minus 2.96 percent versus the Xetra close of October 19, 2026 at EUR 58.15.
Second-quarter revenue reached EUR 217.06 million
The latest reported period gives investors a stronger operating anchor than the rating change alone. Investing.com reported second-quarter revenue of EUR 217.06 million, net income of EUR 30.78 million and earnings per share of EUR 0.76, compared with a forecast of EUR 0.71. The revenue figure and profit relate to the quarter ended June 30, 2026, and the earnings-per-share comparison shows the reported result against consensus.
Price position remains close to the target
The current Lang & Schwarz price sits EUR 0.43, or 0.77 percent, above Degroof Petercam's EUR 56.00 target dated October 16, 2026. That narrow gap leaves the analyst view nearly aligned with the latest euro quotation, while the stock remains EUR 1.72 below the Xetra close of October 19, 2026. A separate market quotation showed a 52-week range of EUR 49.90 to EUR 85.95 as of October 20, 2026, placing the current price EUR 29.52 below the high and EUR 6.53 above the low.
Results are due on October 28
The next scheduled company event is the third-quarter and nine-month results release on October 28, 2026. MarketScreener lists that date in Melexis's financial calendar. The same page identifies Melexis as an Euronext Brussels semiconductor company and lists an average target of EUR 75.54 from 13 analysts, although the article's latest named house view is Degroof Petercam's EUR 56.00 target.
Melexis stock and the next market check
The immediate investor comparison is therefore between the EUR 56.00 analyst target, the EUR 56.43 Lang & Schwarz quotation and the October 28 reporting date. The next results will provide the next concrete test for the revenue and earnings-per-share figures reported for the second quarter. Melexis stock was trading at EUR 56.43 at Lang & Schwarz on October 20, 2026 at 3:34 p.m. CEST, minus 2.96 percent versus the Xetra close of October 19, 2026 at EUR 58.15. The further course of trading is shown by the continuously updated real-time quote of Melexis stock.
Melexis stock facts
- Company: Melexis N.V.
- ISIN: BE0165385973
- Ticker: MEX
- Primary exchange: Euronext Brussels
- Price Lang & Schwarz (as of October 20, 2026, 3:34 p.m. CEST): EUR 56.43
- Change versus Xetra close: minus 2.96 percent
- Xetra close (October 19, 2026): EUR 58.15
- Market capitalization: EUR 2.6 billion (as of October 20, 2026)
- 52-week range: EUR 49.90-EUR 85.95 (as of October 20, 2026)
- Sector / Industry: Technology / Semiconductors
- Next earnings date: October 28, 2026
Market context: Market report Euro Stoxx 50.
